These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 25384485)

  • 41. Annular pustules in Kawasaki disease: a further case indicating the association with psoriasis?
    Tsai HJ; Wu WM; Chang YC; Wang CM; Hong HS
    Cutis; 2003 Nov; 72(5):354-6. PubMed ID: 14655772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical features of atypical Kawasaki disease.
    Hsieh YC; Wu MH; Wang JK; Lee PI; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2002 Mar; 35(1):57-60. PubMed ID: 11950122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kawasaki disease: characteristics, diagnosis, and unusual presentations.
    Jindal AK; Pilania RK; Prithvi A; Guleria S; Singh S
    Expert Rev Clin Immunol; 2019 Oct; 15(10):1089-1104. PubMed ID: 31456443
    [No Abstract]   [Full Text] [Related]  

  • 44. Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin.
    Shirley DA; Stephens I
    Pediatr Infect Dis J; 2010 Oct; 29(10):978-9. PubMed ID: 20431427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The mucocutaneous lymph node syndrome (Kawasaki syndrome). A case with gallbladder hydrops and coronary artery aneurysm].
    Fritz ME; Giambonini S; Jenni R; D'Apuzzo V
    Schweiz Med Wochenschr; 1981 Apr; 111(16):566-71. PubMed ID: 7233135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics of children with Kawasaki disease requiring intensive care: 10 years' experience at a tertiary pediatric hospital.
    Kuo CC; Lee YS; Lin MR; Hsia SH; Chen CJ; Chiu CH; Hwang MS; Huang YC
    J Microbiol Immunol Infect; 2018 Apr; 51(2):184-190. PubMed ID: 27591913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Continuous Hemofiltration Plus Plasma Exchange in Patient with Kawasaki Disease Shock Syndrome: A Case Report and Literature Review.
    Miao H; Cui Y; Wang F; Zhang Y; Wang C
    Ann Clin Lab Sci; 2019 Nov; 49(6):829-834. PubMed ID: 31882435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Development of diagnosis].
    Ogata S; Ishii M
    Nihon Rinsho; 2008 Feb; 66(2):301-6. PubMed ID: 18260329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Capillary leak leading to shock in Kawasaki disease without myocardial dysfunction.
    Natterer J; Perez MH; Di Bernardo S
    Cardiol Young; 2012 Jun; 22(3):349-52. PubMed ID: 21933461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recurrent Kawasaki disease in a child with retropharyngeal involvement: a case report and literature review.
    Aldemir-Kocabaş B; Kcal MM; Ramoğlu MG; Tutar E; Fitöz S; Çiftçi E; İnce E
    Medicine (Baltimore); 2014 Dec; 93(29):e139. PubMed ID: 25546657
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Kawasaki disease: new and important problems in cardiology].
    Kato H; Ichinose E
    J Cardiogr; 1983 Sep; 13(3):731-47. PubMed ID: 6678300
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Facial nerve palsy complicating Kawasaki disease.
    Wright H; Waddington C; Geddes J; Newburger JW; Burgner D
    Pediatrics; 2008 Sep; 122(3):e783-5. PubMed ID: 18678602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.
    Newburger JW; Takahashi M; Beiser AS; Burns JC; Bastian J; Chung KJ; Colan SD; Duffy CE; Fulton DR; Glode MP
    N Engl J Med; 1991 Jun; 324(23):1633-9. PubMed ID: 1709446
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A case of incomplete Kawasaki disease with extremely high serum ferritin and interleukin-18 levels.
    Noto T; Seto H; Fukuhara J; Murabayashi M; Yachie A; Ayusawa M; Morioka I
    BMC Pediatr; 2018 Dec; 18(1):386. PubMed ID: 30541507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Therapeutic difficulties in a 3 year-old boy with Kawasaki disease].
    Floriańczyk T; Werner B; Gołąbek-Dylewska M
    Kardiol Pol; 2011; 69(12):1273-5. PubMed ID: 22219106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A severe form of Kawasaki disease presenting with only fever and cervical lymphadenopathy at admission.
    Nomura Y; Arata M; Koriyama C; Masuda K; Morita Y; Hazeki D; Ueno K; Eguchi T; Kawano Y
    J Pediatr; 2010 May; 156(5):786-91. PubMed ID: 20097355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kawasaki disease resistant to immunoglobulin G therapy.
    Venugopalan P; Jaya S; Al-Azri MA; Piopongco E
    Ann Trop Paediatr; 2003 Sep; 23(3):187-91. PubMed ID: 14567834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An unusual case of incomplete Kawasaki disease in an adolescent returning from holiday in Montana.
    Hyams C; Day TG; Ramroop S; Paget S; Howard S; McMillan M; Vora S; de Keyser P
    Pediatr Cardiol; 2012 Oct; 33(7):1196-9. PubMed ID: 22398636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resistant Kawasaki disease treated with anti-CD20.
    Sauvaget E; Bonello B; David M; Chabrol B; Dubus JC; Bosdure E
    J Pediatr; 2012 May; 160(5):875-6. PubMed ID: 22341587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.